Ether

Ether

SCHEMBL67441

CCOCC.OCC(CO)(CO)CO

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
TSHR P16473 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL11667411 0.97 ALDH1A1 (0.43) ALDH1A1TSHR
Ether SCHEMBL3841375 0.94 ALDH1A1 (0.48) ALDH1A1TSHR
Ether SCHEMBL2589990 0.91 ALDH1A1 (0.39) ALDH1A1TSHR
Ether SCHEMBL21722990 0.88 ALDH1A1 (0.41) ALDH1A1TSHR
Ether SCHEMBL626792 0.88 ALDH1A1 (0.41) ALDH1A1TSHR
Ether SCHEMBL2591410 0.87 ALDH1A1 (0.36) ALDH1A1
Ether SCHEMBL27914150 0.87 ALDH1A1 (0.39) ALDH1A1TSHR
Ether SCHEMBL4702561 0.87 ALDH1A1 (0.36) ALDH1A1
Ether SCHEMBL1462917 0.85 ALDH1A1 (0.39) ALDH1A1TSHR
Glycerin SCHEMBL21878917 0.84 ALDH1A1 (0.43) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118185295-A Self-lubricating temperature-resistant corrosion-resistant polyurethane modified material and preparation method thereof 广东欧特派环保材料科技有限公司 2024-06-14 CN claimed
EP-4355286-A1 SOLID PERSONAL CARE COMPOSITIONS INCORPORATING NATURAL BENEFIT AGENTS SUCH AS FLAXSEED OIL AND METHODS FOR THE SAME Colgate-Palmolive Company (US) 2024-04-24 EP claimed
CN-117735943-A PUC composite material and preparation method thereof 龙马铝业集团有限公司 2024-03-22 CN claimed
CN-117700289-A Polyurea fast curing solid propellant 3D printing paste 南京理工大学 2024-03-15 CN claimed
CN-117604944-A Buffering energy-absorbing module, packaging method thereof and car arrester 陕西煤业化工技术研究院有限责任公司 2024-02-27 CN claimed
CN-115651512-B Multifunctional polyaspartic acid ester polyurea and preparation method thereof 中冶武汉冶金建筑研究院有限公司 2023-12-08 CN claimed
CN-117070139-A Low-temperature rapid-curing polyurea coating and curing device thereof 浙江锦丰新材料科技有限公司 2023-11-17 CN claimed
CN-116712357-A Moisturizing lip cream and preparation method thereof 上海科黛生物科技有限公司 2023-09-08 CN claimed
CN-116606447-A Preparation and application of novel flower-like composite flame retardant based on Co/Cu-MOF 青岛理工大学 2023-08-18 CN claimed
CN-116396654-A Old furniture repairing material and preparation process thereof 南京林业大学 2023-07-07 CN claimed
WO-2012099384-A2 MONOMER-BASED CROSS-LINKED COPOLYMER CONTAINING A PHOSPHORYLCHOLINE-LIKE GROUP, INVERSE EMULSION, AND COSMETIC COMPOSITION 주식회사 케이씨아이 (KR) 2012-07-26 WO claimed
US-20120097754-A1 WATER-BASED AIR FRESHENER COMPOSITIONS, SYSTEMS, AND METHODS OF USE THEREOF ANTARES CAPITAL LP, AS SUCCESSOR AGENT 2012-04-26 US claimed
WO-2012054939-A2 WATER-BASED AIR FRESHENER COMPOSITIONS, SYSTEMS, AND METHODS OF USE THEREOF AGILEX FLAVOR & FRAGRANCES (US) 2012-04-26 WO claimed
EP-1123082-B1 PREPARATIONS FOR TOPICAL APPLICATION OF SUBSTANCES HAVING ANTIANDROGENIC EFFECT AVENTIS PHARMA SA (FR) 2006-03-01 EP claimed
US-6824708-B2 SWITCHABLE BETWEEN STRONGLY AND WEAKLY SCATTERING STATES XEROX CORPORATION 2004-11-30 US claimed
US-20040113123-A1 Liquid crystal compositions including dispersant XEROX CORPORATION 2004-06-17 US claimed
US-20030083322-A1 COMPOSITIONS FOR TOPICAL APPLICATION HAVING ANDREGENIC ACTIONS AVENTIS PHARMA S.A. (FR) 2003-05-01 US claimed
US-6464989-B2 REMAINS STABLE PACKAGED IN FLEXIBLE TUBE; MICROBIOCIDES; FUNGICIDES MELALEUCA INCORPORATED 2002-10-15 US claimed
US-20020001601-A1 TEA TREE OIL EMULSION FORMULATIONS MELALEUCA, INCORPORATED 2002-01-03 US claimed
US-5533532-A Permanent wave compositions and methods REVLON CONSUMER PRODUCTS CORPORATION (US) 1996-07-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083322-A1 COMPOSITIONS FOR TOPICAL APPLICATION HAVING ANDREGENIC ACTIONS NR5A1, CYP17A1, CYP19A1 ALDH1A1 1374/4885TSHR 2469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.